Latest Networking News

City Chic says reduced discounting is lifting margins and store sales, putting the retailer on track for positive first-half EBIT and no drawn debt by the end of January. The improvement comes with revenue still under pressure, particularly in the USA and online channels, leaving the Black Friday and Christmas period decisive.

Arista Networks delivered third-quarter revenue well above its own guidance, with sales reaching US$3.66 billion and GAAP net income hitting US$1.56 billion. The networking specialist is now guiding to as much as US$4.0 billion in fourth-quarter revenue as it expands its AI infrastructure portfolio.

Skyworks Solutions has begun operating as a larger RF semiconductor group after completing its Qorvo combination, targeting at least US$500 million in annual cost synergies. The deal arrives as standalone fiscal 2026 profit and cash flow declined, leaving execution and integration central to the investment case.

Fiserv has reported a US$6.45 billion non-cash goodwill impairment, sending GAAP earnings deeply negative despite adjusted EPS of US$1.75. The payments group reaffirmed its 2026 outlook while doubling its Project Elevate savings target to US$1 billion.

Ball’s operating performance strengthened in the third quarter, with comparable EPS, operating earnings and global shipments all higher year on year. But a US$475 million noncash pension settlement charge pushed the aluminum packaging group to a US$94 million GAAP loss and cash generation remains thin.

Marathon Petroleum reported a sharp third-quarter earnings increase, powered by much stronger refining margins and full refinery utilisation. The company also lifted its dividend, added US$5 billion to its buyback authorisation and agreed to sell two refineries for US$4.2 billion.

Clever Culture Systems has secured $2.6 million to develop APAS Revolution, a smaller benchtop system aimed at pharmaceutical manufacturers not served by its existing platform. The funding combines a discounted share placement with new debt, while commercial launch is targeted for the first half of 2028.

Marine Biomedical has secured US FDA 510(k) clearance for PearlBone, giving Orthocell a clearer path into bone regeneration through its 12% strategic stake and distribution rights. The commercial opportunity is advancing, but revenue, launch timing and definitive distribution arrangements remain undisclosed.

Kimberly-Clark has completed its acquisition of Kenvue, issuing about 281.1 million shares and taking on an integration programme expected to cost US$3.1 billion before tax. The combined group is targeting US$2.1 billion in annual run-rate synergies by reshaping its brands, segments and operating model.

Marvell is seeking to absorb Lumentum in a US$115 billion all-stock deal that would unite electrical interconnect, lasers and optical networking under one roof. The companies are pitching a US$550 billion addressable market and more than US$1 billion in annual synergies, but completion remains well into the future and subject to regulatory and shareholder approval.

Fox delivered a sharp first-quarter lift, with revenue up 22% and adjusted EBITDA up 54% as World Cup coverage, political advertising and Tubi drove a powerful television result. The catch is that a meaningful share of the uplift came from event-linked revenue and higher sports programming costs.

Nexsen has secured ISO 13485 certification covering the design, development and manufacture of its StrepSure Group B Streptococcus diagnostic. The milestone strengthens the product’s regulatory and manufacturing platform, but does not yet amount to FDA or TGA approval.